Revisiting fetal dose during radiation therapy: Evaluating treatment techniques and a custom shield

Amir M. Owrangi, Donald A. Roberts, Elizabeth L. Covington, James A. Hayman, Kathryn M. Masi, Choonik Lee, Jean M. Moran, Joann I. Prisciandaroa

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

To create a comprehensive dataset of peripheral dose (PD) measurements from a new generation of linear accelerators with and without the presence of a newly designed fetal shield, PD measurements were performed to evaluate the effects of depth, field size, distance from the field edge, collimator angle, and beam modifiers for common treatment protocols and modalities. A custom fetal lead shield was designed and made for our department that allows external beam treatments from multiple angles while minimizing the need to adjust the shield during patient treatments. PD measurements were acquired for a comprehensive series of static fields on a stack of Solid Water. Additionally, PDs from various clinically relevant treatment scenarios for pregnant patients were measured using an anthropomorphic phantom that was abutted to a stack of Solid Water. As expected, the PD decreased as the distance from the field edge increased and the field size decreased. On average, a PD reduction was observed when a 90° collimator rotation was applied and/or when the tertiary MLCs and jaws defined the field aperture. However, the effect of the collimator rotation (90° versus 0°) in PD reduction was not found to be clinically significant when the tertiary MLCs were used to define the field aperture. In the presence of both the MLCs and the fetal shield, the PD was reduced by 58% at a distance of 10 cm from the field edge. The newly designed fetal shield may effectively reduce fetal dose and is relatively easy to setup. Due to its design, we are able to use a broad range of treatment techniques and beam angles. We believe the acquired comprehensive PD dataset collected with and without the fetal shield will be useful for treatment teams to estimate fetal dose and help guide decisions on treatment techniques without the need to perform pretreatment phantommeasurements.

Original languageEnglish (US)
Pages (from-to)34-46
Number of pages13
JournalJournal of Applied Clinical Medical Physics
Volume17
Issue number5
DOIs
StatePublished - Jan 1 2016

Fingerprint

Radiotherapy
Dosimetry
radiation therapy
dosage
Patient treatment
Linear accelerators
collimators
Water
Therapeutics
Lead
Particle Accelerators
Clinical Protocols
Jaw
apertures
linear accelerators
pretreatment
water

Keywords

  • Fetal shield
  • Fetus
  • Out-of-field dose
  • Peripheral dose

ASJC Scopus subject areas

  • Radiation
  • Instrumentation
  • Radiology Nuclear Medicine and imaging

Cite this

Revisiting fetal dose during radiation therapy : Evaluating treatment techniques and a custom shield. / Owrangi, Amir M.; Roberts, Donald A.; Covington, Elizabeth L.; Hayman, James A.; Masi, Kathryn M.; Lee, Choonik; Moran, Jean M.; Prisciandaroa, Joann I.

In: Journal of Applied Clinical Medical Physics, Vol. 17, No. 5, 01.01.2016, p. 34-46.

Research output: Contribution to journalArticle

Owrangi, AM, Roberts, DA, Covington, EL, Hayman, JA, Masi, KM, Lee, C, Moran, JM & Prisciandaroa, JI 2016, 'Revisiting fetal dose during radiation therapy: Evaluating treatment techniques and a custom shield', Journal of Applied Clinical Medical Physics, vol. 17, no. 5, pp. 34-46. https://doi.org/10.1120/jacmp.v17i5.6135
Owrangi, Amir M. ; Roberts, Donald A. ; Covington, Elizabeth L. ; Hayman, James A. ; Masi, Kathryn M. ; Lee, Choonik ; Moran, Jean M. ; Prisciandaroa, Joann I. / Revisiting fetal dose during radiation therapy : Evaluating treatment techniques and a custom shield. In: Journal of Applied Clinical Medical Physics. 2016 ; Vol. 17, No. 5. pp. 34-46.
@article{90218cd043814a889d7196dcb45789ca,
title = "Revisiting fetal dose during radiation therapy: Evaluating treatment techniques and a custom shield",
abstract = "To create a comprehensive dataset of peripheral dose (PD) measurements from a new generation of linear accelerators with and without the presence of a newly designed fetal shield, PD measurements were performed to evaluate the effects of depth, field size, distance from the field edge, collimator angle, and beam modifiers for common treatment protocols and modalities. A custom fetal lead shield was designed and made for our department that allows external beam treatments from multiple angles while minimizing the need to adjust the shield during patient treatments. PD measurements were acquired for a comprehensive series of static fields on a stack of Solid Water. Additionally, PDs from various clinically relevant treatment scenarios for pregnant patients were measured using an anthropomorphic phantom that was abutted to a stack of Solid Water. As expected, the PD decreased as the distance from the field edge increased and the field size decreased. On average, a PD reduction was observed when a 90° collimator rotation was applied and/or when the tertiary MLCs and jaws defined the field aperture. However, the effect of the collimator rotation (90° versus 0°) in PD reduction was not found to be clinically significant when the tertiary MLCs were used to define the field aperture. In the presence of both the MLCs and the fetal shield, the PD was reduced by 58{\%} at a distance of 10 cm from the field edge. The newly designed fetal shield may effectively reduce fetal dose and is relatively easy to setup. Due to its design, we are able to use a broad range of treatment techniques and beam angles. We believe the acquired comprehensive PD dataset collected with and without the fetal shield will be useful for treatment teams to estimate fetal dose and help guide decisions on treatment techniques without the need to perform pretreatment phantommeasurements.",
keywords = "Fetal shield, Fetus, Out-of-field dose, Peripheral dose",
author = "Owrangi, {Amir M.} and Roberts, {Donald A.} and Covington, {Elizabeth L.} and Hayman, {James A.} and Masi, {Kathryn M.} and Choonik Lee and Moran, {Jean M.} and Prisciandaroa, {Joann I.}",
year = "2016",
month = "1",
day = "1",
doi = "10.1120/jacmp.v17i5.6135",
language = "English (US)",
volume = "17",
pages = "34--46",
journal = "Journal of Applied Clinical Medical Physics",
issn = "1526-9914",
publisher = "American Institute of Physics Publising LLC",
number = "5",

}

TY - JOUR

T1 - Revisiting fetal dose during radiation therapy

T2 - Evaluating treatment techniques and a custom shield

AU - Owrangi, Amir M.

AU - Roberts, Donald A.

AU - Covington, Elizabeth L.

AU - Hayman, James A.

AU - Masi, Kathryn M.

AU - Lee, Choonik

AU - Moran, Jean M.

AU - Prisciandaroa, Joann I.

PY - 2016/1/1

Y1 - 2016/1/1

N2 - To create a comprehensive dataset of peripheral dose (PD) measurements from a new generation of linear accelerators with and without the presence of a newly designed fetal shield, PD measurements were performed to evaluate the effects of depth, field size, distance from the field edge, collimator angle, and beam modifiers for common treatment protocols and modalities. A custom fetal lead shield was designed and made for our department that allows external beam treatments from multiple angles while minimizing the need to adjust the shield during patient treatments. PD measurements were acquired for a comprehensive series of static fields on a stack of Solid Water. Additionally, PDs from various clinically relevant treatment scenarios for pregnant patients were measured using an anthropomorphic phantom that was abutted to a stack of Solid Water. As expected, the PD decreased as the distance from the field edge increased and the field size decreased. On average, a PD reduction was observed when a 90° collimator rotation was applied and/or when the tertiary MLCs and jaws defined the field aperture. However, the effect of the collimator rotation (90° versus 0°) in PD reduction was not found to be clinically significant when the tertiary MLCs were used to define the field aperture. In the presence of both the MLCs and the fetal shield, the PD was reduced by 58% at a distance of 10 cm from the field edge. The newly designed fetal shield may effectively reduce fetal dose and is relatively easy to setup. Due to its design, we are able to use a broad range of treatment techniques and beam angles. We believe the acquired comprehensive PD dataset collected with and without the fetal shield will be useful for treatment teams to estimate fetal dose and help guide decisions on treatment techniques without the need to perform pretreatment phantommeasurements.

AB - To create a comprehensive dataset of peripheral dose (PD) measurements from a new generation of linear accelerators with and without the presence of a newly designed fetal shield, PD measurements were performed to evaluate the effects of depth, field size, distance from the field edge, collimator angle, and beam modifiers for common treatment protocols and modalities. A custom fetal lead shield was designed and made for our department that allows external beam treatments from multiple angles while minimizing the need to adjust the shield during patient treatments. PD measurements were acquired for a comprehensive series of static fields on a stack of Solid Water. Additionally, PDs from various clinically relevant treatment scenarios for pregnant patients were measured using an anthropomorphic phantom that was abutted to a stack of Solid Water. As expected, the PD decreased as the distance from the field edge increased and the field size decreased. On average, a PD reduction was observed when a 90° collimator rotation was applied and/or when the tertiary MLCs and jaws defined the field aperture. However, the effect of the collimator rotation (90° versus 0°) in PD reduction was not found to be clinically significant when the tertiary MLCs were used to define the field aperture. In the presence of both the MLCs and the fetal shield, the PD was reduced by 58% at a distance of 10 cm from the field edge. The newly designed fetal shield may effectively reduce fetal dose and is relatively easy to setup. Due to its design, we are able to use a broad range of treatment techniques and beam angles. We believe the acquired comprehensive PD dataset collected with and without the fetal shield will be useful for treatment teams to estimate fetal dose and help guide decisions on treatment techniques without the need to perform pretreatment phantommeasurements.

KW - Fetal shield

KW - Fetus

KW - Out-of-field dose

KW - Peripheral dose

UR - http://www.scopus.com/inward/record.url?scp=84995582000&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84995582000&partnerID=8YFLogxK

U2 - 10.1120/jacmp.v17i5.6135

DO - 10.1120/jacmp.v17i5.6135

M3 - Article

C2 - 27685109

AN - SCOPUS:84995582000

VL - 17

SP - 34

EP - 46

JO - Journal of Applied Clinical Medical Physics

JF - Journal of Applied Clinical Medical Physics

SN - 1526-9914

IS - 5

ER -